FDA Approved: ESBRIET — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ESBRIET (pirfenidone) submitted by Genentech, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Esbriet (pirfenidone)

Snippet

SUPPL AP for ESBRIET (PIRFENIDONE)